Amgen Inc
Lobbyists Employed
-
Johnson, Deron A
(Details)305 Stable View Ct
Parkton, MD 21120
(410) 357-5776
Registered: 5/4/2012
Matters: Issues pertaining to the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors
Job title: Senior Manager, State Government Affairs
-
Snider, Kipp
(Details)601 13th St NW
Fl 12
Washington, DC 20005
(202) 585-9640
Registered: 2/21/2013
Matters: Issues pertaining to the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors
Job title: Director, State Government Affairs
Lobbyists Retained
-
Bear, Catherine
Firm: State & Federal Communications
(Details)3800 Powell Ln
APT 207
Falls Church, VA 22041
(703) 379-1335
Registered: 2/5/2013
Firm: State & Federal Communications
Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability
-
Cox, Tyler Siegel
Firm: Hancock Daniel & Johnson PC
(Details)4701 Cox Rd
STE 400
Glen Allen, VA 23060
(804) 967-9604
Registered: 8/16/2012
Firm: Hancock Daniel & Johnson PC
Matters: All matters pertaining to pharmaceuticals.
-
Duvall, Charles R Jr
Firm: Lindl Corp
(Details)PO Box 170
Richmond, VA 23218
(804) 644-7884
Registered: 1/21/2013
Firm: Lindl Corp
Matters: All matters pertaining to pharmaceuticals.
-
Johnson, W Scott
Firm: Hancock Daniel & Johnson PC
(Details)4701 Cox Rd
Ste 400
Glen Allen, VA 23060
(804) 967-9604
Registered: 5/7/2012
Firm: Hancock Daniel & Johnson PC
Matters: All matters pertaining to pharmaceuticals.
-
Lawrence, Timothy
Firm: State & Federal Communications
(Details)1101 K St NW
Suite 310
Washington, DC 20005
(202) 365-7457
Registered: 1/16/2013
Firm: State & Federal Communications
Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability
-
Metheny, Wesley
Firm: State & Federal Communications
(Details)1101 K Street NW
Suite 310
Washington, DC 20005
(202) 731-3381
Registered: 1/16/2013
Firm: State & Federal Communications
Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability
-
Seibert, Aimee Perron
Firm: Hillbridge Group
(Details)28 N 8th St
Fl 1
Richmond, VA 23219
(804) 647-3140
Registered: 2/1/2013
Firm: Hillbridge Group
Matters: Issues pertaining to patient protections with respect to biosimilar interchangeability.
-
Whitehead, David Calloway III
Firm: Whitehead Consulting
(Details)28 N 8th St
Fl 2
Richmond, VA 23219
(804) 389-2825
Registered: 1/22/2013
Firm: Whitehead Consulting
Matters: Issues pertaining to patient protections with respect to biosimilar interchangeablitity and the sales, marketing, and reimbursement of pharmaceuticals in the public and private sectors
HB1374
Summary judgment; use of depositions.
Chief Patron:
Christopher Head
Status: Consolidated
HB1422
Interchangeable biosimilar biological products; permits pharmacists to dispense, etc.
Chief Patron:
John O'Bannon
Status: Enacted
HB1500
Budget Bill.
Chief Patron:
Lacey Putney
Status: Enacted
HB1501
Pharmacy; collaborative agreements.
Chief Patron:
John O'Bannon
Status: Enacted
HB1516
Pharmacies; access to the Prescription Monitoring Program.
Chief Patron:
Lynwood Lewis
Status: Killed
HB1551
Discovery rule; statute of limitations.
Chief Patron:
Manoli Loupassi
Status: Killed
HB2312
Pharmacies; clarifies definition of compounding, etc.
Chief Patron:
Chris Jones
Status: Enacted
SB800
Budget Bill.
Chief Patron:
Walter Stosch
Status: Killed
SB945
Patient assistance programs; work group to develop recommendations regarding specialty drug needs.
Chief Patron:
Toddy Puller
Status: Killed
SB1139
Discovery rule; statute of limitations.
Chief Patron:
Donald McEachin
Status: Killed
SB1285
Interchangeable biosimilar biological products; permits pharmacists to dispense, etc.
Chief Patron:
Steve Newman
Status: Enacted
Principal contact for Amgen Inc:
-
Kathy Feegel
601 13th St NW
Fl 12
Washington, DC 20005
(202) 585-9614
Information on this page comes from public documents on file with the office of the Virginia Conflict of Interest and Ethics Advisory Council.